HK1215594A1 - 用於指示侵襲性前列腺癌的存在或不存在的方法 - Google Patents
用於指示侵襲性前列腺癌的存在或不存在的方法Info
- Publication number
- HK1215594A1 HK1215594A1 HK16103559.9A HK16103559A HK1215594A1 HK 1215594 A1 HK1215594 A1 HK 1215594A1 HK 16103559 A HK16103559 A HK 16103559A HK 1215594 A1 HK1215594 A1 HK 1215594A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- indicating
- prostate cancer
- aggressive prostate
- aggressive
- cancer
- Prior art date
Links
- 206010060862 Prostate cancer Diseases 0.000 title 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 title 1
Classifications
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57434—Specifically defined cancers of prostate
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Pathology (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Hospice & Palliative Care (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Medicinal Chemistry (AREA)
- Evolutionary Biology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Theoretical Computer Science (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Medical Informatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE1251312 | 2012-11-20 | ||
SE1350600 | 2013-05-16 | ||
PCT/EP2013/074259 WO2014079865A1 (en) | 2012-11-20 | 2013-11-20 | Method for indicating a presence or non-presence of aggressive prostate cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1215594A1 true HK1215594A1 (zh) | 2016-09-02 |
Family
ID=49619938
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK16103559.9A HK1215594A1 (zh) | 2012-11-20 | 2016-03-29 | 用於指示侵襲性前列腺癌的存在或不存在的方法 |
Country Status (15)
Country | Link |
---|---|
US (1) | US10431326B2 (zh) |
EP (2) | EP3327146A1 (zh) |
JP (2) | JP2016503301A (zh) |
KR (1) | KR20150110477A (zh) |
AU (1) | AU2013349801B2 (zh) |
BR (1) | BR112015011359B1 (zh) |
CA (2) | CA3092807C (zh) |
DK (1) | DK2922967T3 (zh) |
ES (1) | ES2667326T3 (zh) |
HK (1) | HK1215594A1 (zh) |
IL (1) | IL238724A0 (zh) |
MY (1) | MY182773A (zh) |
RU (1) | RU2675370C2 (zh) |
WO (1) | WO2014079865A1 (zh) |
ZA (1) | ZA201503460B (zh) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI638277B (zh) | 2012-03-05 | 2018-10-11 | Opko診斷法有限責任公司 | 用於確定前列腺癌相關事件之機率之分析系統及方法 |
JP2016508026A (ja) | 2012-11-20 | 2016-03-17 | ファディア・アクチボラゲットPhadia AB | 前立腺癌を有する個体の予後診断方法 |
EP4220170A3 (en) | 2014-03-11 | 2023-12-13 | Phadia AB | Method for detecting a solid tumor cancer |
MY192513A (en) | 2014-03-28 | 2022-08-24 | Opko Diagnostics Llc | Compositions and methods related to diagnosis of prostate cancer |
ES2867798T3 (es) | 2015-03-27 | 2021-10-20 | Opko Diagnostics Llc | Estándares del antígeno prostático y usos de estos |
US9858665B2 (en) * | 2015-04-03 | 2018-01-02 | Regents Of The University Of Minnesota | Medical imaging device rendering predictive prostate cancer visualizations using quantitative multiparametric MRI models |
AU2016254127B2 (en) * | 2015-04-29 | 2022-05-26 | Opko Diagnostics, Llc | Compositions and methods for active surveillance of prostate cancer |
WO2017164699A1 (ko) * | 2016-03-24 | 2017-09-28 | 서울대학교병원 (분사무소) | 전립선암과 관련된 단일염기다형성 및 이를 이용한 유전 위험도 점수의 개발 |
ES2688213T3 (es) * | 2016-07-15 | 2018-10-31 | Proteomedix Ag | Método para detectar proteínas en muestras humanas y usos de dichos métodos |
JP7138112B2 (ja) * | 2017-02-01 | 2022-09-15 | ファディア・アクチボラゲット | 特定の特徴を有する個体において前立腺癌の存在または不存在を示すための方法 |
KR102093453B1 (ko) * | 2018-01-08 | 2020-03-25 | (주)인실리코젠 | 체형 및 대사 감수성 snp 마커 및 진단정보 제공방법 |
WO2019144112A1 (en) | 2018-01-22 | 2019-07-25 | Phadia Ab | Method for the harmonization of assay results |
IT201800021394A1 (it) * | 2018-12-28 | 2020-06-28 | Daniela Terracciano | Metodo in vitro per la diagnosi del cancro alla prostata |
US11633146B2 (en) | 2019-01-04 | 2023-04-25 | Regents Of The University Of Minnesota | Automated co-registration of prostate MRI data |
US11631171B2 (en) | 2019-01-10 | 2023-04-18 | Regents Of The University Of Minnesota | Automated detection and annotation of prostate cancer on histopathology slides |
CN109628564B (zh) * | 2019-02-25 | 2022-02-01 | 北京市理化分析测试中心 | 一种用于检测snp多态性的引物组和利用引物组检测snp多态性的方法 |
KR102068667B1 (ko) * | 2019-02-28 | 2020-01-21 | 주식회사 프로카젠 | 전립선암 유전위험점수 산출장치, 산출방법 및 이의 기록매체 |
KR102371654B1 (ko) * | 2019-02-28 | 2022-03-08 | 주식회사 프로카젠 | 유전 변이의 개수에 따른 예측력을 고려한 전립선암 유전위험점수 산출장치, 산출방법 및 이의 기록매체 |
KR102068666B1 (ko) * | 2019-02-28 | 2020-02-11 | 주식회사 프로카젠 | 인종 별 전립선암 유전위험점수 산출장치, 산출방법 및 이의 기록매체 |
KR102371655B1 (ko) * | 2019-02-28 | 2022-03-08 | 주식회사 프로카젠 | 각 유전 변이 정보에 개별적인 가중치를 부여한 전립선암 유전위험점수 산출장치, 산출방법 및 이의 기록매체 |
IT202000029948A1 (it) * | 2020-12-04 | 2022-06-04 | Nib Biotec S R L | Metodo per la diagnosi di tumore alla prostata in pazienti in differente fascia di età |
GB2599198B (en) * | 2021-06-15 | 2022-12-07 | A3P Biomedical Ab | A method for determining an appropriate time interval for further diagnostic testing for prostate cancer |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030219840A1 (en) | 2002-05-24 | 2003-11-27 | Mikolajczyk Stephen D. | Method of analyzing proenzyme forms of prostate specific antigen in serum to improve prostate cancer detection |
FR2934698B1 (fr) | 2008-08-01 | 2011-11-18 | Commissariat Energie Atomique | Procede de prediction pour le pronostic ou le diagnostic ou la reponse therapeutique d'une maladie et notamment du cancer de la prostate et dispositif permettant la mise en oeuvre du procede. |
WO2010081240A1 (en) * | 2009-01-19 | 2010-07-22 | Miraculins Inc. | Diagnostic assays for prostate cancer using psp94 and psa biomarkers |
WO2010093939A2 (en) | 2009-02-12 | 2010-08-19 | Dana-Farber Cancer Institute, Inc. | Predicting and treating prostate cancer |
WO2011150515A1 (en) * | 2010-06-01 | 2011-12-08 | Universite Laval | Prognostic markers for prostate cancer recurrence |
EP2611943B1 (en) | 2010-09-03 | 2017-01-04 | Wake Forest University Health Sciences | Methods and compositions for correlating genetic markers with prostate cancer risk |
US20120202888A1 (en) | 2010-10-08 | 2012-08-09 | The Brigham And Women's Hospital, Inc. | Biomarkers of prostate cancer and predicting mortality |
US20120150032A1 (en) * | 2010-12-13 | 2012-06-14 | Julius Gudmundsson | Sequence Variants Associated with Prostate Specific Antigen Levels |
EP2850432A2 (en) | 2012-05-16 | 2015-03-25 | Phadia AB | Method for indicating the presence or non-presence of prostate cancer |
JP2016508026A (ja) | 2012-11-20 | 2016-03-17 | ファディア・アクチボラゲットPhadia AB | 前立腺癌を有する個体の予後診断方法 |
-
2013
- 2013-11-20 ES ES13792689.5T patent/ES2667326T3/es active Active
- 2013-11-20 WO PCT/EP2013/074259 patent/WO2014079865A1/en active Application Filing
- 2013-11-20 CA CA3092807A patent/CA3092807C/en active Active
- 2013-11-20 AU AU2013349801A patent/AU2013349801B2/en active Active
- 2013-11-20 CA CA2891392A patent/CA2891392C/en active Active
- 2013-11-20 US US14/443,970 patent/US10431326B2/en active Active
- 2013-11-20 MY MYPI2015701578A patent/MY182773A/en unknown
- 2013-11-20 RU RU2015124054A patent/RU2675370C2/ru active
- 2013-11-20 DK DK13792689.5T patent/DK2922967T3/en active
- 2013-11-20 BR BR112015011359-1A patent/BR112015011359B1/pt active IP Right Grant
- 2013-11-20 EP EP17210720.3A patent/EP3327146A1/en not_active Withdrawn
- 2013-11-20 JP JP2015542308A patent/JP2016503301A/ja active Pending
- 2013-11-20 KR KR1020157015113A patent/KR20150110477A/ko not_active Application Discontinuation
- 2013-11-20 EP EP13792689.5A patent/EP2922967B1/en active Active
-
2015
- 2015-05-10 IL IL238724A patent/IL238724A0/en unknown
- 2015-05-18 ZA ZA2015/03460A patent/ZA201503460B/en unknown
-
2016
- 2016-03-29 HK HK16103559.9A patent/HK1215594A1/zh unknown
-
2018
- 2018-10-04 JP JP2018189147A patent/JP2019049559A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
US10431326B2 (en) | 2019-10-01 |
KR20150110477A (ko) | 2015-10-02 |
BR112015011359A2 (pt) | 2017-07-11 |
RU2675370C2 (ru) | 2018-12-19 |
MY182773A (en) | 2021-02-05 |
BR112015011359A8 (pt) | 2019-10-01 |
CA3092807A1 (en) | 2014-05-30 |
AU2013349801B2 (en) | 2019-03-07 |
IL238724A0 (en) | 2015-06-30 |
EP2922967A1 (en) | 2015-09-30 |
WO2014079865A1 (en) | 2014-05-30 |
BR112015011359B1 (pt) | 2022-12-06 |
RU2015124054A (ru) | 2017-01-10 |
ZA201503460B (en) | 2018-11-28 |
CA2891392C (en) | 2020-11-03 |
CA3092807C (en) | 2024-02-27 |
EP3327146A1 (en) | 2018-05-30 |
EP2922967B1 (en) | 2018-01-03 |
CN105051206A (zh) | 2015-11-11 |
JP2019049559A (ja) | 2019-03-28 |
JP2016503301A (ja) | 2016-02-04 |
AU2013349801A1 (en) | 2015-05-28 |
US20150317431A1 (en) | 2015-11-05 |
DK2922967T3 (en) | 2018-04-16 |
CA2891392A1 (en) | 2014-05-30 |
ES2667326T3 (es) | 2018-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1215594A1 (zh) | 用於指示侵襲性前列腺癌的存在或不存在的方法 | |
IL237791B (en) | A method for treating cancer | |
IL228538B (en) | A method for identifying cancers that may respond to immunoprecipitation against folr1 | |
SG11201503893RA (en) | Method of treating cancer | |
EP2815070A4 (en) | CALIBRATION BASED ON AN INVERSION OF ELECTROMAGNETIC TOOLS IN THE BOTTOM OF A HOLE | |
SG11201510210XA (en) | Methods for detecting prostate cancer | |
EP2698634A4 (en) | BIOMARKER FOR BREAST CANCER | |
EP2668295A4 (en) | METHODS OF DETECTING LUNG CANCER | |
EP2876447A4 (en) | METHOD OF DETECTING CANCER | |
EP2895206A4 (en) | METHOD FOR TREATING CARCINOMA | |
EP2851688A4 (en) | MARKER FOR THE DETECTION OF PANCREATIC CANCER | |
EP2686447A4 (en) | PROGNOSTIC MARKER SETS FOR PROSTATE CANCER | |
EP2876446A4 (en) | METHOD OF DETECTING CANCER | |
HK1220253A1 (zh) | 診斷前列腺癌症的方法 | |
IL232493A0 (en) | A method for quantifying cancer treatment | |
EP2699699A4 (en) | METHOD FOR THE DIAGNOSIS OF CANCER | |
EP2894477A4 (en) | METHOD FOR DETECTION OF BREAST CANCER | |
GB2510539B (en) | Biomarkers of cancer | |
HK1200502A1 (zh) | 判定患者前列腺癌預測的方法 | |
EP2771695A4 (en) | METHOD OF DETECTION OF BREAST CANCERS | |
EP2888594A4 (en) | METHOD OF DETERMINING TREATMENT FOR USE AGAINST BREAST CANCER | |
EP2882869A4 (en) | PROSTATE CANCER GENE EXPRESSION PROFILES | |
GB201004304D0 (en) | Biomarkers for prostate cancer | |
GB201218219D0 (en) | Nucleic acid biomarkers for prostate cancer | |
IL229109A0 (en) | Cancer diagnosis |